EU regulators approve plasma device from Cytomedix

12/12/2012 | MassDevice.com (Boston)

Cytomedix has earned CE mark approval in Europe for use of its Angel concentrated platelet-rich plasma technology with bone marrow aspirate. The system, which was cleared by the FDA last month, includes adjustable settings to allow customized processing and preparation of plasma in clinical settings or at the point of care.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA